These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 31308726)
21. Pharmacogenomics for personalized pain medicine. Ko TM; Wong CS; Wu JY; Chen YT Acta Anaesthesiol Taiwan; 2016 Mar; 54(1):24-30. PubMed ID: 26976339 [TBL] [Abstract][Full Text] [Related]
22. [Personalized dosing from perspective of pharmacogenomics of drug metabolizing enzymes and transporters]. Zhou Q; Yu LS; Zeng S Yao Xue Xue Bao; 2017 Jan; 52(1):1-7. PubMed ID: 29911367 [TBL] [Abstract][Full Text] [Related]
23. Genetic databases and their potential in pharmacogenomics. Lagoumintzis G; Poulas K; Patrinos GP Curr Pharm Des; 2010; 16(20):2224-31. PubMed ID: 20459387 [TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics of analgesic drugs. Cregg R; Russo G; Gubbay A; Branford R; Sato H Br J Pain; 2013 Nov; 7(4):189-208. PubMed ID: 26516523 [TBL] [Abstract][Full Text] [Related]
25. Personalized Medicine: Pharmacogenomics and Drug Development. Mirsadeghi S; Larijani B Acta Med Iran; 2017 Mar; 55(3):150-165. PubMed ID: 28282716 [TBL] [Abstract][Full Text] [Related]
26. Pharmacogenomics signature: A novel strategy on the individual differences in drug response. Guo C; Lin X; Yin J; Xie X; Li J; Meng X; Wu J; Huang L; Huang Z; Yang G; Zhou H; Chen X Cancer Lett; 2018 Apr; 420():190-194. PubMed ID: 29432844 [TBL] [Abstract][Full Text] [Related]
27. Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer. Bell GC; Donovan KA; McLeod HL Cancer Control; 2015 Oct; 22(4):426-32. PubMed ID: 26678969 [TBL] [Abstract][Full Text] [Related]
28. The pharmacogenomics of pain management: prospects for personalized medicine. Ting S; Schug S J Pain Res; 2016; 9():49-56. PubMed ID: 26929662 [TBL] [Abstract][Full Text] [Related]
29. The role and impact of SNPs in pharmacogenomics and personalized medicine. Laing RE; Hess P; Shen Y; Wang J; Hu SX Curr Drug Metab; 2011 Jun; 12(5):460-86. PubMed ID: 21453271 [TBL] [Abstract][Full Text] [Related]
30. Awareness survey of parties involved in pharmacogenomics in Japan. Tamaoki M; Gushima H; Tsutani K Pharmacogenomics; 2007 Mar; 8(3):275-86. PubMed ID: 17324116 [TBL] [Abstract][Full Text] [Related]
31. The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery. Yan Q Methods Mol Biol; 2008; 448():1-19. PubMed ID: 18370227 [TBL] [Abstract][Full Text] [Related]
32. Pharmacogenomics in dermatology: Taking patient treatment to the next level. Schweitzer J; Maibach H J Dermatolog Treat; 2015 Feb; 26(1):94-6. PubMed ID: 24552417 [TBL] [Abstract][Full Text] [Related]
33. Implementation of a multidisciplinary pharmacogenomics clinic in a community health system. Dunnenberger HM; Biszewski M; Bell GC; Sereika A; May H; Johnson SG; Hulick PJ; Khandekar J Am J Health Syst Pharm; 2016 Dec; 73(23):1956-1966. PubMed ID: 27864203 [TBL] [Abstract][Full Text] [Related]
34. A Primer to Pharmacogenetics of Postoperative Pain Management. Aroke EN; Kittelsrud JM AANA J; 2019 Apr; 87(2):131-137. PubMed ID: 31587726 [TBL] [Abstract][Full Text] [Related]
35. Genetic predisposition to adverse drug reactions in the intensive care unit. Empey PE Crit Care Med; 2010 Jun; 38(6 Suppl):S106-16. PubMed ID: 20502164 [TBL] [Abstract][Full Text] [Related]
36. Biomedical informatics methods in pharmacogenomics. Yan Q Methods Mol Med; 2005; 108():459-86. PubMed ID: 16028700 [TBL] [Abstract][Full Text] [Related]